Osaic Holdings’s Olema Pharmaceuticals OLMA Stock Holding History

Osaic Holdings’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.73K	Sell	218 -99	-31%	-$1.33K	﹤0.01%	7173
2026 Q1	$4.73K	Sell	317 -157	-33%	-$3.5K	﹤0.01%	6711
2025 Q4	$11.8K	Buy	+474	New	+$8.43K	﹤0.01%	6230
2025 Q3	–	Sell	-5	Closed	-$21	–	7971
2025 Q2	$21	Buy	+5	New	+$22	﹤0.01%	7658
2025 Q1	–	Sell	-385	Closed	-$2.25K	–	7646
2024 Q4	$2.25K	Sell	385 -558	-59%	-$5.57K	﹤0.01%	6567
2024 Q3	$11.3K	Buy	943 +238	+34%	+$3.04K	﹤0.01%	5746
2024 Q2	$7.63K	Buy	705 +355	+101%	+$3.85K	﹤0.01%	5951
2024 Q1	$3.96K	Buy	+350	New	+$4.52K	﹤0.01%	6198
2023 Q4	–	Sell	-1	Closed	-$12	–	7416
2023 Q3	$12	Buy	+1	New	+$10	﹤0.01%	7332

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Osaic Holdings's OLMA Position: Q2 2026 in Review

Osaic Holdings reduced its Olema Pharmaceuticals (OLMA) stake by 31% in Q2 2026, selling an estimated $1.33K and leaving 218 shares worth $2.73K. The position accounts for ﹤0.01% of the portfolio, ranked #7173.

Osaic Holdings first reported a position in OLMA in Q3 2023 and has held it in 9 quarters since. The position peaked at $11.8K in Q4 2025. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

Osaic Holdings held 218 shares of Olema Pharmaceuticals worth $2.73K as of Q2 2026.
Osaic Holdings sold 99 Olema Pharmaceuticals shares in Q2 2026, an estimated $1.33K.
Olema Pharmaceuticals made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7173 holding.
Osaic Holdings first reported a position in Olema Pharmaceuticals in Q3 2023 and has held it in 9 quarters since.
Osaic Holdings's Olema Pharmaceuticals position peaked at $11.8K in Q4 2025.
185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.